Events

Kevin Outterson, CARB-X Executive Director, and Karen Gallant, CARB-X Global R&D Project Director, present details of CARB-X’s four new funding rounds announced April 30, 2019, and answer questions during this webinar. To attend the live webinar, please register by clicking the link below. A recording of the webinar will be available for viewing shortly after […]

Despite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds, which mainly come from mining various chemical libraries. In this webinar, Carl Balibar […]

Participants include Kevin Outterson, Executive Director of CARB-X. The Global AMR R&D Hub is pleased to announce a one-day workshop on “Increasing Investments for AMR R&D”, which will take place on Tuesday May 28 2019 in Geneva, Switzerland. The event will gather representatives from governments, funders, industry, investors and other stakeholders interested in the field of […]

Presentation by Karen Gallant, CARB-X Acting R&D Chief/Deputy Director.  Attendees include Richard Alm, CARB-X Alliance Director. Please join NCBiotech and RTI International as we host CARB-X Global R&D Project Director Karen Gallant for an informational session about CARB-X and the upcoming funding rounds. Karen will provide an overview of the CARB-X initiative and leave plenty […]

The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy. The key benefits of attending the […]

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this webinar the recording of Carl Balibar's presentation 'Mining of chemical libraries for new antibacterials' (original webinar on 21 May) will be followed by another live […]

Panelists members include Kevin Outterson, Executive Director of CARB-X, on the “Public-Private Partnerships: Research and Development Consortia and Accelerators” panel. This panel will discuss the use of public-private partnerships as models for stimulating innovation through sponsored research and development. The panelists will provide overviews of several partnership-enabled consortia and accelerators, including BARDA’s new Division of Research, […]

Interested in new funding opportunities for infection drug development? The Cystic Fibrosis Foundation (CFF) has teamed up with CARB-X to host a live webinar on June 11, from 10:00am – 11:00am ET, to introduce their new Infection Research Initiative. During the webinar, Dr. Ann Field, Senior Director of Drug Discovery and Development at the Cystic […]

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this webinar, William J. Weiss, Director, PreClinical Services, University of North Texas System College of Pharmacy, will introduce experimental design of animal models for antimicrobial research. […]

Each day at ASM Microbe 2019 offers you the chance to delve into your scientific interest and specialties, discover cutting-edge research in the poster and oral presentations, and connect with a world of microbiology experts. View the ASM Microbe 2019 Schedule at a Glance for a preliminary peek at what is in store for you.